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The origin of tissue mast cells has been a subject of controversy for nearly a century 
since the first description of the cells by Ehrlich  (1,  2).  Many authors believed that 
mast  cells  developed  locally  from  certain  types  of  connective  tissue  cells  (1-4). 
Ginsburg and  coworkers  (5-7)  and  Ishizaka et  al.  (8,  9)  claimed the  importance of 
lymphoid cells as a  source of mast  cell precursors, based on  the in vitro experiments 
that demonstrated the development of mast cells from thymus and lymph node cells. 
Burnet  presented a  hypothesis that  mast cells, or some subpopulations of mast  cells, 
were  postmitotic derivatives of thymus-derived  (T)  lymphocytes  (10).  Recently,  we 
have shown  that  mice of two  mutant  genotypes are useful  for the investigations on 
the origin of mast cells. Giant granules of beige (C57BL/6-bgJ/bg s, Chediak-Higashi 
syndrome)  mice can be used as a  marker for mast  cells of the donor origin  (11,  12). 
WBB6F1-W/W"  mice are also useful  because  they  lack tissue mast  cells owing to a 
defect in mast cell precursors (13,  14).  By using these mutant  mice, we demonstrated 
the presence of mast cell precursors in the bone marrow (11-14)  and peripheral blood 
of adult  mice  (15)  and  in  the  liver  of mouse  embryos  (16).  To  clarify  the  above 
mentioned  apparent  discrepancy, we studied the distribution of the  precursor cells, 
which  differentiate into mast  cells in  vivo, in  lymphoid tissues of mice by using our 
experimental systems. We have shown  that  the concentration of mast cell precursors 
in the thymus,  lymph node, and  Peyer's patch  is <0.1%  of the concentration  in  the 
bone  marrow  and  that  the  thymus  and  T  lymphocytes  are  not  essential  for  the 
differentiation of the precursor cells into mature mast cells. 
Materials  and  Methods 
Mice.  WBB6F1  ONB-W/ +  X  C57BL/6-WV/ + )-W/W  v  and  their  normal  littermates 
(WBB6FI-+/+),  WCB6F1  (WC-SI/ +  X  C57BL/6-Sld/ + )  -SI/SI d  mice,  and  C57BL/ 
6-bgJ/bg J  mice and  their normal littermates (C57BL/6-bgJ/+  or  +/+)  were raised in our 
laboratory using parental stocks originally obtained from The Jackson Laboratory, Bar Harbor, 
Maine, or were purchased from The Jackson Laboratory. Nude, athymic (BALB/c-nu/nu)  mice 
were raised and  kindly given by  Dr.  T. Tanabe  (Research Institute for Microbiol Diseases, 
Osaka University), and were kept within a filter-air laminar flow enclosure. 
Thymectomy.  The operation was carried out under Nembutal (Abbott Laboratories, North 
Chicago, Ill.) anesthesia 4 wk before irradiation and cell injection. The success of the thymec- 
tomy was confirmed at  the time of the sacrifice and the animals with thymus renmant  were 
discarded. 
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FIG.  1.  Experimental design  for detection of mast  cell  precursors  in  the thymus.  Same for the 
lymph node and Peyer's patch as well. 
Cell  Preparation  and  Treatment  with  Anti-Thy-l.2  Serum.  Cells  were  suspended  in  Eagle's 
medium  by  the  method  described  previously  (17).  In  one  experiment,  bone  marrow  cells 
(BMC) t were treated with anti-Thy-1.2 alloantiserum and complement according to the method 
described  by  Yutoku  et  al.  (18).  The  antiserum,  prepared  by  immunizing  AKR  mice with 
thymus  cells of C3H  mice  (19),  was  kindly  given  by  Dr.  M.  Yotoku  (Institute  for  Cancer 
Research,  Osaka  University).  1 ml of 1:4 dilution  of anti-Thy-l.2  serum  and,  as  a  source of 
complement,  1 ml by  1:4  dilution of rabbit  serum which had been previously absorbed  with 
mouse  spleen  cells,  were  added  to  5  ×  10  v BMC  in  1 ml  Eagle's  medium.  The  cells were 
incubated at 37°C for 45 min with shaking and then washed with cold Eagle's medium. When 
cell viability was  determined  by  the  trypan-blue  dye exclusion technique,  viability of BMC 
after the treatment with the antiserum and complement was --~90%, whereas the viability of the 
thymus cells (TC) after the same treatment  was <5%. 
Cell  Transfer.  Two experimental systems were used. Cells were transplanted  between histo- 
compatible donors and hosts in both systems to avoid complicate aUogenic effects. 
In  the  system  I,  WBB6FyW/W  v  mice  were  injected  with  cells  of congenic  +/+  mice 
intravenously at 6 wk of age. Repeated biopsies of the skin of the back were carried out under 
ether anesthesia to find the variation of mast-cell number in one animal. The  W/W v recipient 
mice were killed  15 wk after the cell injection, a  piece of dorsal skin, the stomach, cecum, and 
mesentery were removed .(Fig.  1). 
In  the system  II, cells were  injected  intravenously  into  C57BL/6-+/+  mice after whole 
body x-irradiation (800 rads). The condition of irradiation has been described (20). To examine 
the presence of mast  cell precursors  in the thymus  and  lymph node, TC or lymph node cells 
d  d  (LNC)  of C57BL/6-bg  /bg  mice were mixed with  BMC of C57BL/6-+/+  mice, and  then 
injected  into  irradiated  C57BL/6-+/+  mice  (Fig.  1).  The  cells  with  giant  granules  were 
assumed  to be derived from TC or LNC of C57BL/6-bgJ/bg a mice. The BMC of C57BL/6- 
+/+  mice were added  because  the injection of TC or LNC  alone does  not  rescue 800-rad 
irradiated mice. 
Blood Examination.  Blood samples were obtained from lateral tail veins at various times after 
cell  transfer.  When  cells of WBB6Fy+/+  mice  were  injected  into  WBB6Ft-W/W v  mice, 
number  of erythrocytes  was  counted  with  hemocytometer.  When  cells from  beige C57BL/6 
mice were injected into normal C57BL/6 mice, blood smears were fixed in formaldehyde vapor, 
stained with Sudan Black B, and counterstained with Giemsa solution (21, 22).  100 neutrophils 
with distinctly segmented nuclei were scored for the presence or absence of giant granules. 
Determination of Mast  Cell Development.  A  piece of dorsal skin, the stomach, and cecum were 
gently smoothed onto a  piece of thick filter paper to keep them flat and fixed in  10% buffered 
formalin  (pH  7.2).  The stretch  preparation  of the mesentery was  also  fixed in  10%  formalin. 
Tissues were embedded in paraffin; 5-/tin thick sections, and stretched  mesentery were stained 
with acidified toluidine blue (pH 3.0). 
In the system I  (Fig.  1), the number of mast cells was evaluated according to the previously 
1Abbreviations used in  this paper: BMC, bone marrow cells(s);  LNC,  lymph node cell(s);  PPC,  Peyer's 
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TABLE  I 
Criteria for Increase of Erythrocytes and Mast Cells in  WBB6F~- W~ W ~ Mice by Injection of Cells from 
Congenic +/+ Mice 
Mice 
Erythrocytcs 
Mean ntlmber of cells  ±  SE (range)* 
Mast cells:~ 
Glandular store- 
Skin  Forestomach  ach  ('ccum  Mesentcry 
X  IOn/mm 3 
WBB6Fr+/+  9.3 ±  0.2  393 ±  34  124  ±  16  103  +  19  5.7  -*  1.2  659 +-  73 
(8.4  -  10.8)  (204  - 674)  (44 - 242)  (42  324)  (0,4  .-  14.6)  (156  1263) 
WBB6FI-W/[4" (non-  5.2  ±  0.3  08  ±  0. l  0  0  0  0 
treated)  {3.1  - 7.1)  {IJ.2  22)  (0)  (t))  (0)  (D) 
Criteria for increase  >8.0  >20  >20  >20  >5  >50 
* Values obtained from  15 WBB6Fr  +/+  mice and  15 WBB6Fr  ~4'/W" mice, 18-24 wk of age at the time of study. 
.~ Numbcl of ma.st cells  pel  centimetcl in the skin,  foestomach, glandttlar stomach, and cecum; pet' centlmetet squared of the membranous 
part o[  ~  1he mescntcry. 
described method under the microscope (13). The number of mast cells in the skin, stomach, 
and  cecum  was  expressed  as  mast  cells  per  centimeter. The  number of mast  cells  in  the 
mesentery was expressed  as mast cells per centimeter squared. 
In the system II (Fig.  1), the proportion of mast cells with giant granules was scored.  More 
than 200 mast cells were  counted in the skin, stomach, and mesentery; >50 mast cells were 
counted in the cecum. 
Criteria for Increase of Mast Cells and E~ythrocytes.  The number of mast cells in each tissue of 
individual WBB6FI-W~  W ~ recipient mice was considered to be increased by the injection of 
cells from WBB6Fr +/+  mice if the number exceeded the arbitrarily determined values shown 
in Table I. Criterion for the increase of peripheral erythrocyte number is also shown in Table 
I. 
Skin Graft.  A piece of skin m20 X 25 mm in its full thickness,  including  panniculus  carnosus, 
was removed. A small piece (~-20 X  3 mm) was cut from the skin to determine the value of 
mast cells  before grafting. The remaining part  of the  skin was  grafted  on the  back of the 
recipient mouse under Nembutal anesthesia and was kept in place by wound clips. Each mouse 
with a  graft was kept in an individual cage.  Recipient mice were  killed 6 wk after grafting; 
grafts were  removed for counting the number of mast cells. A piece  of the dorsal skin of the 
recipient mice was also removed for comparison. 
Results 
Distribution of Precursor  Cell.  WBB6Fr W~ W v mice were injected with a  fixed dose 
(2  X  107) of BMC,  spleen cells  (SC),  TC,  LNC,  and Peyer's patch  cells  (PPC)  of 
congenic +/+  mice at 6 wk of age  (Fig.  1). Biopsies of the dorsal skin were done 5 
and  10  wk  after  the cell injection. The number of mast  cells in the  skin increased 
significantly 10  wk  after  the  injection of BMC  and  SC  (Fig.  2).  In contrast, such 
increase of mast cells was not observed after the injection ofTC, LNC, and PPC (Fig. 
2). 
WBB6FrW/W  v  recipient  mice  were  killed  15  wk  after  the  cell  injection, and 
number of mast  cells  in  the  skin, stomach,  cecum,  and  mesentery was  evaluated. 
Although injection of BMC and SC increased the number of mast cells in all tissues 
examined, the  injection of TC,  LNC,  and  PPC  increased the  number only in the 
stomach and cecum of <30% of WBB6Fr W/W ~ recipients (Table II). 
In the next experiment, the dose of TC was increased to  108, and that of BMC was 
decreased to  104 for detailed comparison of the concentration of mast cell precursors 
between  the  thymus  and  bone  marrow.  As  shown  in  Fig.  3  and  Table  III,  the Y.  KITAMURA  ET  AL.  485 
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TABLE II 
Increase of Erythrocytes and Mast Cells in  WBB6F:-W/W  v Mice 15  Wk after Injection of a Fixed Dose 
(2 X  ]07) of Various Cells from Congenic +/+ Mice 
Proportion ofcases in which increase was detected 
Mast cells  Cells in-  Erythrocytes 
jected 
Blood  Skin  Forestomach  Glandular  Cecum  Mesentery 
stomach 
BMC  11/11  11/11  11/11  11/11  11/11  10/11 
SC  10/10  10/10  10/10  10/10  10/10  10/10 
TC  0/10  0/10  2/10  3/10  0/9  0/10 
LNC  0/12  0/12  2/12  3/[2  3/12  0/[2 
PPC  0/12  0/12  0/12  1/12  3/12  0/12 
development of mast cells  after  the injection of l0  s TC was significantly  inferior to 
that after the injection of 105 BMC, and was comparable to the value obtained by the 
infection of 104 BMC. 
Experiment  using  the  system  II  also  showed  the  low  concentration  of mast  cell 
precursors  in  lymphoid tissues.  Although  a  considerable  number of mast  cells  with 
giant  granules  appeared  in  the stomach  and  cecum  of C57BL/6-+/+  mice  after 
irradiation and injection of 5  X  105 BMC of C57BL/6-bga/bg a mice, beige-type mast 
cells scarcely developed after injection of either l0  s TC or 5  X  107 LNC from C57BL/ 
6-bga/bg a mice (Table IV). 
Insignificance of T Lymphocytes and Thymus.  T  lymphocytes are known to exist in the 
bone  marrow  (23,  24).  Although  the  concentration  of mast  cell  precursors  in  the 
thymus is negligible when compared to that in the bone marrow, it does not necessarily 
exclude  the  possibility  that  T  lymphocytes  in  the  bone  marrow  may  help  the 
differentiation of precursor cells into mast cells. To examine this possibility, BMC of 
WBB6Fx-+/+  mice  were  injected  into  WBB6FI-W/W v  mice  after  removal  of T 
lymphocytes by  treatment  with  anti-Thy-l.2  serum  and  complement.  As  shown  in 486  ORIGIN  OF  MAST  CELLS 
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TABLE  III 
Ability  of BMC and TC of WBB6F1-+/+ Mice to Increase Erythrocytes and Mast Cells of WBB6FI- 
W~ W ~ Mice 
Proportion of cases in which increase was detected 
Mast cells  Cells in-  Cell  Erythrocytes 
jected  dose 
Blood  Glandular 
Skin  Forestomach  stomach  Cecum  Mesentery 
TC  l0  s  3/15  3/15  8/15  8/15  8/15  5/15 
BMC  104  1/9  1/9  5/9  6/9  4/9  0/9 
l0  s  8/9  8/9  9/9  9/9  9/9  7/8 
106  7/8  8/8  7/7  8/8  8/8  8/8 
10  v  7/7  7/7  7/7  7/7  7/7  7/7 
TABLE  IV 
Appearance of Beige-type Cells in Irradiated Normal C57BL/6 Mice 15 Wk after Injection of Various 
Cells 
Cell iniected 
No of 
BMC  BMC  t'Lor-  TC  I,NC  mice 
beige  mal  beige  beige 
Mean  proportion of beige-type cells 
Neutrophils  Mast  cells 
Forcstom  Glandular 
Blood  Skin  Cecum  Mesentet y 
ach  stomach 
5  ×  l0  s  0  0  0  7  79  0  17  57  39  0 
5  ×  l0  n  0  0  0  7  99  0  15  67  75)  3 
0  5  ×  IO  s  0  (I  I I  0  I)  0  ()  0  0 
0  5  X  I0  ~  I(.)  ~  0  6  0  0  (LI  0  0  0 
0  5  x  I0  n  0  5  X  107  I I  0  0  0  0,2  0  () 
Fig. 4, T-lymphocyte-depleted  BMC  did not cure the anemia  of WBB6F1-W~ W v mice 
as reported  by Wiktor-Jedrzejczak  et al.  (24).  However,  the number  of mast cells was 
increased not  only in the skin  (Fig. 4)  but also in the stomach,  cecum,  and  mesentery 
(data not shown)  by the injection of such T-lymphocyte-depleted  BMC  as well as by 
the injection of nontreated  BMC. Y.  KITAMURA  ET  AI,.  487 
X  2  15~  _~.~k  i  ERYTHROCYTE 
+1  ~  10  --  ++  ,+ 
~.  _z loo? 
u  io 
n 
0  5  10  15 
TIME  AFTER  CELL  INJECTION  (WEEKS) 
Flu,  4.  Number  of peripheral  erythrocytes  and  mast  cells  in  the  skin  of WBB6FrW/W"  mice 
injected with either nontreated BMC or BMC  which had been treated with anti-Thy-1.2 serum and 
complement.  Each point, mean of 7-16 mice. O, nontreated, ©, anti-Thy  1.2  +  C'. 
TABLE  V 
Effect of T-lymphocyte  Removal from Injected BMC and Thymectomy of the Hosts on Appearance of Donor- 
type Cells in Irradiated  Mice * 
Mean proportiun of bcigv-t':  pc ,+:ells (';i) 
Treat mtmt with 
Thymectom~. of  No  t+[-mice  Ncttti'ophils  Mast crlls 
anti-The.- 1"2 st'-  host 
I  um  (;]an~duliu 
Bl~ud  Skin  Ft  n'cst+mlat:h  stomach  (:c<.uni  PV[cst'Ilt+:I  v 
No  No  Ill  lOI)  1.3  I I  59  72  I.~ 
~t  +<~s  No  7  t{}l)  0. I  5  64  83  1.2 
Yes  Yes  8  II)l)  2.0  5  60  80  1.7 
* Non'mat C57B1,/6 mice Will'S'  iniected with 5 ×  l0  s BMC of beige C:')7BL/(i mice after irradiation,  and kiih-d 15 wk latcl 
TABLE  VI 
Development  of Mast Cells in the Skin of WBB6F]-W/ W v Mice Grafted on 
the Back of Nude Athymic Mice 
Number  of mast cells/era  +  SE* 
Skin 
Before grafting  6  wk after grafting 
Graft from  14,'/W  ~'  0.8  +-  0.2  (10)  487  +  45  (9) 
Graft from SI/SI a  0.3  +  0.2  (8)  1.3  +__  0.6  (8) 
Skin of nude host  NE~  416  +  43  (9) 
* Number  of mice is shown in parentheses. 
NE, not examined. 
Insignificance of T  lymphocytes for mast cell differentiation was also demonstrated 
by using the system II.  Neither removal of T  lymphocytes from the donor BMC nor 
thymectomy of the recipient  mice affected  the development of donor-type mast cells 
in the irradiated recipients  (Table V). 
In the last experiment, a piece of the skin of WBB6Fr W~ W v and WCB6FI-SI/SI d 
mice was grafted on the back of nude athymic mice to confirm the insignificance  of 
the  thymus for mast-cell  differentiation.  The number of mast  cells  increased  to  the 
normal level in the skin grafted from WBB6Fr W/W'" mice 6 wk after grafting (Table 
VI),  but  not  a  significant  number  of mast  cells  appeared  in  the  skin  graft  from 488  ORIGIN OF  MAST  CELLS 
WCB6F1-SI/SI  a  mice,  in  which  mast  cells  are  depleted  because  of  a  defect  in 
microenvironment for differentiation of mast cells  (14). 
Discussion 
Concentration of mast cell precursors in the thymus is found to be <0.1% of that in 
the  bone  marrow.  As  the  concentration  in  the  lymph  node  and  Peyer's  patch  is 
comparable to that in the thymus, and as the spleen and fetal liver (16) contained a 
considerable number of mast cell precursors, the main source of the precursor cells  in 
the body seems to be hematopoietic tissues  rather  than  lymphopoietic tissues.  This 
result  is not necessarily contradictory to the in vitro development of mast cells  from 
lymphoid cells  reported  by Ginsburg et  al.  (5-7)  and  Ishizaka et  al.  (8,  9)  because 
mast cells developed in one-half of WBB6F1-W~ W ~ mice injected with a large dose of 
TC (10  s) and because the in vitro technique (5-9) may be more sensitive than in vivo 
method used in the present study. Because improvement of in vitro culture is possible 
by using fibroblasts of mast cell-depleted WBB6FI-W~  W v mice as a  feeder layer and 
giant granules of beige mice as a  marker for the origin of mast cells,  development of 
mast cells  from the bone marrow should be tested by such in vitro system. 
The results  obtained  by the  system  I  (+/+  donors and  W/W  ~ recipients)  were 
consistent with the results obtained by the system II (bgJ/bg J  donors and irradiated 
+ / +  recipients)  with regard to the concentration of mast cell precursors. However, 
beige-type mast cells  scarcely appeared in the skin of C57BL-+/+  mice which had 
been  irradiated  and  injected with  BMC  from C57BL/6-bgJ/bg  a  donors, in  contrast 
with a  significant increase of mast cells  in the skin of WBB6F1-W~ W ~ mice after the 
injection of BMC from the congenic + / +  donors. The presence of mature mast cells 
might inhibit the differentiation of mast cells from their precursors. Although we have 
recently shown that  the development of beige-type mast cells  can be induced in the 
skin  of beige-to-normal radiation chimeras by painting methylcholanthrene  (12),  it 
remains  unclear whether  methylcholanthrene painting affects the differentiation  of 
mast cells  through destruction of mature mast cells. 
As reported by Wiktor-Jedrzejczak et al.  (24),  the T-lymphocyte-depleted BMC of 
WBB6FI-+/+  mice  did  not  cure  the  anemia  of WBB6F~-W/W  v  mice.  However, 
mast cells appeared after the injection of such BMC without T  lymphocytes. Accord- 
ingly, T  lymphocytes do not seem to play an essential role for differentiation of mast 
cells.  This interpretation  was confirmed by the experiment  in which T-lymphocyte- 
depleted  BMC  of C57BL/6-bgJ/bg  J  mice  were  injected  into  thymectomized  and 
irradiated  C57BL/6-+/+  mice.  Number of mast  cells  with  giant  granules  was as 
many as in the nonthymectomized C57BL-+/+  mice injected with nontreated BMC 
of C57BL/6-bga/bg  J  mouse origin. 
A significant number of mast cells appeared in the skin of WBB6F1-W~ W ~ grafted 
on the back of nude, athymic mice. The fact that mast cells did not appear in the skin 
grafted from WCB6F1-St/St  a  mice, which have a  defect in  the stroma for mast cell 
differentiation  (14),  suggests that the appearance of mast cells  in the skin of W/W  ~ 
mice is a  result of differentiation  from precursor cells  rather than simple infiltration 
from neighboring tissues.  The interpretation  is supported by the result of Viklick~ et 
al.  who demonstrated, by radioautography, the proliferation of mast cell precursors 
in the skin of A/H mice grafted to nude, athymic hosts (25). Although Ishizaka et al. 
(8) speculated a possible role of thymic factor on mast cell differentiation, our present Y.  KITAMURA ET  AL.  489 
results do not support the concept. Because mast cells develop not only in the skin but 
also in the stomach, cecum, and mesentery of WBB6F1-W/W ~ mice after the injection 
of BMC from congenic  + /  +  donors, the mast cells in the skin would not be different 
from  mast  cells  in  other  tissues.  Therefore,  the  present  results  suggest  that  the 
differentiation of mast cells may not depend on the thymus in any part of the body. 
Summary 
Two  experimental  systems were  used  to  investigate  the  origin  of precursor cells 
which differentiate into tissue mast cells in vivo. (a) Increase of mast cell number was 
examined in the skin, stomach, cecum, and mesentery of genetically mast cell-depleted 
WBB6F1  (WB  X  C57BL/6)-W/W  v mice after the  injection of various hematolym- 
phoid cells of congenic  + /  +  mice.  (b) Appearance of mast cells with giant granules 
was studied in irradiated C57BL/6-+/+  mice after the injection of lymphoid cells 
of C57BL/6-bga/bg a (beige, Chediak-Higashi syndrome) mice. Concentrations of mast 
cell  precursors  in  the  thymus,  lymph  node  and  Peyer's  patch  were  <0.1%  of the 
concentration  in  the  bone  marrow.  Neither  treatment  of donor  bone  marrow  cells 
with  anti-Thy-l.2  serum  and  complement  nor  thymectomy  of the  recipient  mice 
affects  the  development  of mast  cells in  the  skin,  stomach,  cecum,  and  mesentery. 
Moreover,  the  number  of mast  cells  increased  to  normal  level  when  the  skin  of 
WBB6Fa-W/W v mice was grafted on the back of nude athymic (BALB/c-nu/nu)  mice. 
These results indicate that mast cell precursors are derived from hematopoietic tissues 
rather than lymphopoietic ones and that the differentiation of the precursor cells does 
not depend on T  lymphocytes or the thymus. 
The authors acknowledge the valuable discussion of Doctors K. J.  Mori, K. Takatsu, and K. 
Matsumoto. 
Received for publication  8 May  1979. 
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